vusolimogene,nivolumab,rp2
bms,replimune
['rp2 ', 'rp1', 'melanoma', 'ignyte', '$repl', 'replimune']
$repl replimune presents rp1 data from the ignyte anti-pd1 failed melanoma cohort and rp2 data in uveal melanomas at the 2023 american society of clinical oncology (asco) annual meeting. updated data from ongoing igny te anti- pd1 failed melanoma coh... 
Financial news recaps and ticker rating curated by AI language models. Fine tuned on analyst articles and return alpha. More exposure to lesser known companies.